Winter Capital and McKinsey announce the launch of the third annual startup competition “Pervaya Vysota”
Winter Capital and McKinsey announce the launch of a startup competition “Pervaya Vysota”, which will be held this year for a 3rd time. The winner of the contest will receive $200,000 in equity funding from Winter Capital and a 6-month intensive mentorship program from Winter Capital and McKinsey professionals.
In the first two seasons of Pervaya Vysota more than 400 startups from various fields of the Russian economy have taken part in the competition. Young entrepreneurs have showcased their business ideas in a wide range of online and offline industries - from specialized retail to e-commerce, machine learning, service marketplaces and many others. Four winners of the competition – Particle, Eristica, Gavels and Heedbook – received funding of over $400,000 from Winter Capital.
Pervaya Vysota will accept applications from startups until August 12; the final round of 2018 competition will be held at the McKinsey Moscow office on September 28.
More on pervaya-vysota.ru
UCG has launched production of rubber cables
UCG has launched production of rubber cables at its facility in Podolsk, Moscow region. The new production area is equipped with state-of-the-art extrusion lines supplied by Troester, Germany. With the launch of rubber cable production UCG is able to offer a full range of specialty cables for naval and civil shipbuilding, offshore oil&gas and other demanding industrial applications.
Petrovax has successfully finalized clinical trials of Grippol® Quadrivalent
Petrovax has successfully finalized clinical trials of Grippol® Quadrivalent – the first Russian influenza vaccine that protects against 4 strains of influenza virus.
Quadrivalent influenza vaccines have been recommended by the WHO since 2012. Currently, only five countries in the world manufacture quadrivalent vaccines, namely Australia, USA, Canada, Germany, and France. Russia will be the sixth country to independently manufacture such vaccine.
More on petrovax.com
Winter Capital increases its shareholding in Auto1
Winter Capital continues to increase its ownership in Auto1, the leading European used-car marketplace currently operating in 30 countries.
During its latest round of financing Auto1 was valued at approximately $2.8 billion. Investors in this round included Baillie Gifford & Co, Princeville Global and Target Global. The company valuation has more than doubled since it was valued at approximately $1 billion in a funding round in 2015. Auto1 aims to achieve a 10% market share in mainland Europe in the medium to long term.
More on auto1.com
ZaOdno launches new format of stores
Russian dollar store chain, ZaOdno, launched a new discount format under the “Home Market” brand. 10 pilot stores were opened in the Moscow, Tula and Orel regions in August 2017.
The new concept aims to provide customers with a variety of inexpensive non-food merchandise in easily accessible locations. Each store is around 250-350 m2.
To improve shopping experience Home Market offers a large variety of product categories at low prices.
The new stores are different from traditional ZaOdno stores not only in their product range and pricing policy but also in their design and presentation.
More on homemrkt.ru
Winter Capital and McKinsey launched a startup competition “Pervaya Vysota”
Winter Capital and McKinsey launched the startup competition “Pervaya Vysota” for the second time. This year one winner will receive $200,000 as an investment and mentorship from both Winter Capital and McKinsey professionals. The final round of the competition will take place at Red October on September 22.
In Pervaya Vysota 2016 the three winners were Particle (data searching and analysis platform), Eristica (social betting mobile application) and Gavels (online auctions for residential real estate). Each project received $75,000 as an investment and mentorship.
More on pervaya-vysota.ru
DocPlanner received additional financing in Series D funding round
DocPlanner, one of the largest European SaaS and lead generation platforms for healthcare services, has closed a €15mn Series D funding round, which was led by Target Global, Enern Investments and One Peak Partners. The new funding round follows the merger with Doctoralia, a Spain-based company operating in more than 20 countries, and brings the total amount raised by DocPlanner to €46mn. The company plans to use the new capital to develop offices in Brazil and Mexico, reinforce its marketing and sales operations in core markets as well as improve its product offering to doctors.
More on docplanner.com
Winter Capital announces investment into KidZania – children edutainment parks operator
Winter Capital has invested into Innova Partners, an operator of KidZania parks which provide children aged 4-14 with an opportunity to engage in real life role play experience which blends learning with entertainment. The company launched a park in Moscow in January 2016 and plans to expand its operations into the US, France and Canada. The first US park is expected to be launched in Dallas in 2018. KidZania, launched in 1999, has 24 locations in 19 countries, with another seven locations currently under development.
UCG initiates export sales with the first contract in India
UCG, one of the leading manufacturers of shipbuilding cable across Russia and CIS, signed its first contract with an Indian customer. The company will supply power cables for 7 ships which are being constructed by Larsen & Toubro, one of the largest shipbuilders in India. This contract marks the beginning of UCG’s international expansion as the company plans to bring its expertise and solutions to markets outside of Russia and CIS.
Petrovax became the 1st Russian GMP compliant producer of veterinary products
In October 2016 the Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor) following the audit approved the issuance of a GMP certificate for Petrovax to manufacture the veterinary medicines AZOXIVET and Vetolaza. The Company has taken the lead as the 1st Russian manufacturer of veterinary drugs that complies with the GMP standards approved in Russia.
More on petrovax.com
ZaOdno opened its 100th store
ZaOdno, a leading Russian dollar store operator, has announced the opening of its 100th store, which took place on October 29. Located in Mytishchi, Moscow region, the store occupies 350 square meters of floor space in Krasny Kit, a popular local mall. The store offers a wide range of everyday consumer products, general merchandise and seasonal items. The store’s opening marks another major milestone for the company, which is aiming to become an alternative to traditional retail stores. ZaOdno has been able to significantly broaden its customer base by delivering value on day-to-day purchases, and now has more than 1.5 million monthly visitors. It is expected that the retailer will continue to demonstrate significant growth rates through active expansion into the regions and further diversification of its product range.
More on zaodno.ru
Winter Capital and McKinsey have announced the winners of startup competition
The final round of startup competition “Pervaya Vysota” took place on 12 August at Digital October. The panel of judges (Alexey Bashkirov and Mikhail Tsyferov from Winter Capital Advisors, Dmitry Garanin and Evgeny Yakushkin from McKinsey and Julia Solovieva from Google) have selected 3 winners: Particle (talent search platform), Eristica (social betting mobile application) and Gavels (online auctions for residential real estate). Three winners will receive $75,000 each in exchange for a 10% stake in the company and half-year mentorship from Winter Capital Advisors and McKinsey professionals.
More info on pervaya-vysota.ru
Petrovax launches localization project with Boehringer Ingelheim
Petrovax and Boehringer Ingelheim, a global pharmaceutical company, have signed an agreement to localize the full-cycle production of the most advanced thrombolytic drugs in Russia. The medicines are used for urgent treatment of infarctions and cerebrovascular accidents. The agreement effected as part of Russia's 2020 Pharmaceutical Industry Development Strategy (Pharma 2020). It is another step towards making essential lifesaving medicines more affordable in Russia.
For Boehringer Ingelheim this is the first localization project of its kind: by the end of 2019 Petrovax plans to complete the transfer of technology, quality controls and launch full-cycle production of thrombolytics at its production facility in the Moscow Region.
More on petrovax.com
DocPlanner announces a merger with one of its largest competitors Doctoralia
DocPlanner, one of the largest European SaaS and lead generation platforms for healthcare services, announces a merger with Doctoralia, a Spain-based company operating in more than 20 countries. As a result of the merger the combined entity will become one of the leading online platforms in healthcare globally with presence in Europe, South America and Asia. The merger succeeded spring 2016 Series C round led by Target Global in which DocPlanner raised c. $20mn.
More on docplanner.com
Winter Capital and McKinsey have launched startup competition
Winter Capital and McKinsey have jointly launched startup competition “Pervaya Vysota”. Three winners will receive $75,000 each in exchange for a 10% stake in the company and half-year mentorship from Winter Capital Advisors and McKinsey professionals. The final will take place in Digital October on 12 August.
More on pervaya-vysota.ru
Kazakhstan to use Petrovax’s vaccine for anti-flu vaccination in 2016
Following a government tender, Petrovax was selected as the sole supplier of the full volume of anti-flu vaccine for the 2016-2017 epidemiological season population of Kazakhstan eligible for free vaccination (including children from six months of age, pregnant women, healthcare workers and people aged 60 and over). This is a well-deserved recognition of the efficacy, safety and high quality standards of Petrovax’s product. Importantly, this is the first time Kazakhstan has purchased a Russian vaccine. Previously, anti-flu vaccines has only been supplied by countries outside of the former Soviet Union
More on petrovax.com
ZaOdno received additional financing from Winter Capital Partners
ZaOdno, one of the fastest-growing dollar store chains in Russia, has received additional financing from Winter Capital Partners. The company will use the majority of the proceeds to further expand its footprint in Central Russia. The remaining funds will be spent on improving logistics, merchandising and CRM capabilities.
More on zaodno.ru
Petrovax to localize flu vaccine production in Iran
On 19 February 2016, Petrovax, Sobhan Recombinant Protein and Arvin LTD signed a trilateral strategic cooperation agreement to localize the production of Grippol® Plus flu vaccine in Iran. The signing took place at Petrovax's production facility and was attended by representatives of the Deputy Health Minister and Head of the Food and Drug Organization of the Islamic Republic of Iran. As part of the cooperation, Petrovax will transfer its full-cycle production technology for the Russian Grippol® Plus flu vaccine to Sobhan Recombinant Protein (Iran) and train the Iranian company’s staff to replicate all production stages. Currently, Petrovax is the only Russian pharmaceutical company working to localize manufacturing of its innovative medicines in Iran.
More on petrovax.com